About Index Trending news
Analyze
Pricing
Endocyte

Endocyte

Endocyte

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital
$15,000,000
Venture capital (Series C)
$26,000,000
Employees

Unknown size

Xconomy

Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal

Health
Xconomy

Endocyte Cuts Workforce by 40 Percent After Clinical Trial Falters

Health Strategy